INFLIXIMAB

167022 reported adverse events

Drug classes: Tumor Necrosis Factor Blocker [EPC]

These side effects are most commonly reported by patients taking INFLIXIMAB:

# Side effect Count
0 DRUG INEFFECTIVE 30914
1 OFF LABEL USE 22060
2 INFUSION RELATED REACTION 14138
3 RHEUMATOID ARTHRITIS 13906
4 PAIN 12721
5 ARTHRALGIA 11480
6 CONDITION AGGRAVATED 10925
7 FATIGUE 10618
8 PRODUCT USE ISSUE 10606
9 DRUG INTOLERANCE 8911
See all common reactions for INFLIXIMAB

INFLIXIMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 272 0.9252
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 3022 0.8967
2 SWOLLEN JOINT COUNT INCREASED 657 0.8760
3 RED BLOOD CELL SEDIMENTATION RATE 202 0.8670
4 PEMPHIGUS 5488 0.7792
5 RHEUMATIC FEVER 818 0.7616
6 RHEUMATOID FACTOR POSITIVE 2188 0.7125
7 GRANULOMA SKIN 437 0.6621
8 DUODENAL ULCER PERFORATION 1872 0.6230
9 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 83 0.5971
See all enriched reactions for INFLIXIMAB